These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8125835)

  • 1. Development of infection with Streptococcus bovis and Aspergillus sp. in irradiated mice after glycopeptide therapy.
    Brook I; Tom SP; Ledney GD
    J Antimicrob Chemother; 1993 Nov; 32(5):705-13. PubMed ID: 8125835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin and penicillin G combination therapy in prevention of bacterial translocation and animal mortality after irradiation.
    Brook I; Ledney GD
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1685-7. PubMed ID: 1929342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral aminoglycoside and ofloxacin therapy in the prevention of gram-negative sepsis after irradiation.
    Brook I; Ledney GD
    J Infect Dis; 1991 Nov; 164(5):917-21. PubMed ID: 1940469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of resistant gram-positive infection: value of glycopeptide antibiotics vancomycin and teicoplanin].
    Waldvogel F
    Schweiz Med Wochenschr; 1993 Dec; 123(50):2353-6. PubMed ID: 8272810
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.
    Jensen KT; Schønheyder H; Pers C; Thomsen VF
    APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolone and glycopeptide therapy for infection in mouse following exposure to mixed-field neutron-gamma-photon radiation.
    Brook I; Tom SP; Ledney GD
    Int J Radiat Biol; 1993 Dec; 64(6):771-7. PubMed ID: 7903345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
    Harland S; Tebbs SE; Elliott TS
    J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging glycopeptide resistance in gram-positive organisms.
    von Gottberg A; Ferraz V; Dusé AG
    S Afr Med J; 2000 Nov; 90(11):1108-9. PubMed ID: 11196027
    [No Abstract]   [Full Text] [Related]  

  • 10. Short and long courses of ofloxacin therapy of Klebsiella pneumoniae sepsis following irradiation.
    Brook I; Ledney GD
    Radiat Res; 1992 Apr; 130(1):61-4. PubMed ID: 1561319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A closer look at vancomycin, teicoplanin, and antimicrobial resistance.
    Zeckel ML
    J Chemother; 1997 Oct; 9(5):311-31; discussion 332-5. PubMed ID: 9373787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What do I need to know about glycopeptide antibiotics?
    Li S; Starkey ES
    Arch Dis Child Educ Pract Ed; 2016 Dec; 101(6):323-326. PubMed ID: 27389546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A; Debbia EA; Bacca D; Balistreri G; Musolino B; Schito GC
    Drugs; 1997; 54 Suppl 6():11-20. PubMed ID: 9474477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral ofloxacin therapy of Pseudomonas aeruginosa sepsis in mice after irradiation.
    Brook I; Ledney GD
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1387-9. PubMed ID: 2117418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antimicrobial therapy on the gastrointestinal bacterial flora, infection and mortality in mice exposed to different doses of irradiation.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Jan; 33(1):63-72. PubMed ID: 8157575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of gram-positive therapy in the neutropenic patient.
    Menichetti F; Del Favero A
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():51-60. PubMed ID: 1829077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
    Lefort A; Arthur M; Depardieu F; Chau F; Pouzet C; Courvalin P; Fantin B
    J Infect Dis; 2004 Jan; 189(1):90-7. PubMed ID: 14702158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-gram-positive agents. What we have and what we would like.
    Grüneberg RN
    Drugs; 1997; 54 Suppl 6():29-38. PubMed ID: 9474479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.
    Guskey MT; Tsuji BT
    Pharmacotherapy; 2010 Jan; 30(1):80-94. PubMed ID: 20030476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.